'김갑성' 기자의 전체기사
-
A.D.A.M. Innovations and SOPHiA GENETICS partner to advance li…
ROLLE, Switzerland and TOKYO, Oct. 16, 2025 -- A.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company pioneering data-driven medicine, today announced at ESMO a strategic agreement to bring cutting-edge liquid biopsy genomic testing to the Japanese population. The companies will also partner to commercialize a liquid biopsy companion diagnostic aimed at advancing personalized and precision cancer care in Japan. As a market leader for genetic testing in Japan with a high-throughput laboratory located in
- 김갑성 기자
- 2025-10-16 23:00
-
Clarity signs copper-67 Supply Agreement with Nusano
SYDNEY, Oct. 16, 2025 -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a Supply Agreement for copper-67 with Nusano, Inc. ("Nusano"). Nusano's 190,000 square foot state-of-the-art facility in West Valley City, Utah is expected to begin operations in late 2025 with copper-67 isotope supply planned to commence in mid-2026. The propri
- 김갑성 기자
- 2025-10-16 21:04
-
Acron Aviation and Airbus Join Forces to Offer an Upgrade So…
ST. PETERSBURG, Fla. and TOULOUSE, France, Oct. 16, 2025 -- Acron Aviation, a global leader in aerospace safety systems, and Airbus, have announced a collaboration to deliver an upgrade solution for Airbus' operators worldwide. Certified, Compliant, and Configurable Acron Aviation's 25-hour Cockpit Voice Recorder (CVR), marketed as SRVIVR25, is Airbus' chosen solution for 25-hour CVR with recording capability. SRVIVR25, the only 25-hour CVR approved and qualified by Airbus thus far, is fully compliant with the Federal Aviation Administration (FAA) Reauthorization
- 김갑성 기자
- 2025-10-16 21:00
-
Volpara Earns ACR® Learning Network Vendor Partner Design…
LYNNWOOD, Wash., Oct. 16, 2025 -- Volpara Health has qualified for the American College of Radiology® (ACR®) Learning Network Vendor Partner designation. Volpara Health partnered with one of the latest graduates of the ACR ImPower Program Mammography Positioning Improvement Collaborative to identify opportunities to improve breast cancer detection through optimized mammography positioning. Poor mammogram quality contributes to undetected breast cancer, with suboptimal positioning as the primary factor leading to technically inadequate exams. In most health systems, only
- 김갑성 기자
- 2025-10-16 21:00
-
Cell Publishes Breakthrough Research Results of IASO Bio's A…
SHANGHAI, NANJING, China and PLEASANTON, Calif., Oct. 16, 2025 -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative cell therapies, today announced that the Cell published results from the study evaluating its independently developed fully human anti-BCMA CAR-T cell therapy, Equecabtagene Autoleucel (Eque-cel), for the treatment of progressive multiple sclerosis (PMS). This landmark study provides the world's first clinical evidence confirming the safety and efficacy of a CAR-T the
- 김갑성 기자
- 2025-10-16 20:45
-
Unixell Biotech reported a case study of UX-DA001, an iPSC-der…
SHANGHAI, Oct. 16, 2025 -- Unixell Biotech, a clinical-stage bitotech company focused on developing innovative cell therapies for Parkinson's disease (PD) and other neurological disorders, announced positive 6-month follow-up data from the first patient in its phase 1 clinical trial for UX-DA001, an iPSC-derived autologous cell therapy for PD. These data were presented on October 8th at the International Congress of Parkinson's Disease and Movement Disorders (MDS), Honolulu, USA. UX-DA001 is the world's first autologous cell therapy product for Parkinson's Disease which has both received clin
- 김갑성 기자
- 2025-10-16 20:35
-
마이크로밴 인터내셔널, 신임 사장으로 셔먼 맥밀런 임명
헌터스빌, 노스캐롤라이나, 2025년 10월 16일 -- 항균 및 악취 방지 솔루션 분야의 글로벌 선도 기업 마이크로밴 인터내셔널(Microban International)이 오늘 셔먼 맥밀런(Shermon McMillan)을 신임 사장으로 임명했다고 발표했다. 글로벌 포춘 500대 기업에서 성장 전략을 성공적으로 이끌어온 그는 향후 마이크로밴의 전략, 운영, 혁신 파이프라인을 이끌어 지속 가능한 성장을 추진할 예정이다. 마이크로밴의 모회사 바 브랜즈 인터내셔널(Barr Brands International)의 스콧 빌(Scott Beal) 최고경영자(CEO)는 "셔먼 맥밀런은 마이크로밴의 목표를 정확히 이해하고 이를 실현할 수 있는 전략적이고 노련한 리더"라며 "그의 리더십 아래 마이크로밴 브랜드가 한층 강화되고, 글로벌 시장에서의 선도적 위치를 유지할 것이라 확신한다"라고 말했다. 사장으로서 맥밀런은 마이크로밴 브랜드 구축 및 제품 보호 분야에서 가장 신뢰받는 브랜드로 회사의 명성을 높이는 데 주력할 예정이다. 그는 고객 중심, 혁신 실행의 우선순위화, 브랜드 자산
- 김갑성 기자
- 2025-10-16 20:16
-
Microban International Appoints Shermon McMillan as New P…
HUNTERSVILLE, N.C., Oct. 16, 2025 -- Microban International, the global leader in antimicrobial and odor control solutions, today announced the appointment of Shermon McMillan as its new president. A seasoned global executive with a proven record of driving growth at Fortune 500 companies, McMillan will guide Microban strategy, operations and innovation pipeline toward sustainable growth. "Shermon McMillan is a strategic and experienced leader who understands Microban's goals and how to bring them to fruition," said Scott Beal, CEO at Barr Brands International
- 김갑성 기자
- 2025-10-16 20:16
-
Avathon Launches Autonomy for Aerospace Operations
[ 메디채널 김갑성 기자 ] Autonomy has moved beyond the cockpit to the factory floor, the hangar, and the supply chain—transforming Aerospace Operations PLEASANTON, Calif., Oct. 16, 2025 -- Avathon today announced the launch of Autonomy for Aerospace Operations, a unified AI and knowledge platform that connects manufacturing, supply chain, and maintenance data to drive coordinated decision-making across the aerospace lifecycle. By integrating insights from production quality, Bill of Materials (BOM), supplier sourcing, parts availability, and workforce capacity, the platform ena
- 김갑성 기자
- 2025-10-16 19:00
-
NUH And NUS Launch New Molecular Imaging And Theranos…
Powered by Singapore's first next-generation total-body PET/CT system, the new facility aims to transform diagnostics, treatment and research in cancer and beyond SINGAPORE, Oct. 16, 2025 -- The National University Hospital (NUH) and the National University of Singapore (NUS) Clinical Imaging Research Centre (CIRC) have jointly launched the Molecular Imaging and Theranostic Centre, a novel integrated clinical, education, research & development facility that brings together advanced diagnostics, targeted therapy and pioneering research. This landmark development is set
- 김갑성 기자
- 2025-10-16 17:55
- 1포리프 굿마팻 (누바디 굿바이 마이팻) 다이어트 건강기능식품 출시
- 22021년 식품분석전문가 1급/2급 검정자격시험 안내
- 3투썸플레이스, 초콜릿 애프리콧 무스 출시
- 4만성질환자들의 유료독감백신접종에 정책적인 배려가 필요하다
- 5아임웹, CRM 기능 출시… 고객 행동 데이터 기반 마케팅 지원
- 6하만카돈, AURA STUDIO 4 블루투스 스피커 출시
- 7대구오페라하우스 - 20주년 기념 골든 보이스 시리즈Ⅲ, 테너 콘서트
- 82021년 대학생기자단 모집
- 9대한약물영양의학회 2020년 추계학술대회
- 10대한영양제처방학회 춘계학술대회 성황리에 마쳐
2025-10-19_SUN
- 내면의 조화를 발견하세요: '원더풀 인도네시아 웰니스 페스티벌 2025' 개최 01:50
- 제2회 마나르 아부다비 출품 작가 명단 공개 00:48
- 중국-피지 어업 협력, 섬나라 경제 활력 끌어올리다 00:00
2025-10-18_SAT
- The 6th International Ancient Capitals Forum Kicks off in Luoyang, Focusing on the Sustainable Development of Ancient Capitals 23:08
- Kelun-Biotech Presents Positive Results of Phase 3 Clinical Study OptiTROP-Breast02 for Sacituzumab Tirumotecan in Advanced HR+/HER2- Breast Cancer at 2025 ESMO 22:46
- China's Sichuan Extends Cultural Tourism Invitations at Global Landmarks 21:20
- Manulife Hong Kong and JUST FEEL Promote Emotional Well-Being with City's First "My Flag Day" 16:23
발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.
UPDATE: 2025년 10월 19일 03시 20분